Pengaruh Pemberian Hard Candy dari Infusa Kopi Hijau Robusta (Coffea canefora L.) Pada Pasien Diabetes Mellitus

Rusman Rusman; Nur Alfiah Irfiyanti

doi:10.37311/jsscr.v4i2.14183

Pengaruh Pemberian Hard Candy dari Infusa Kopi Hijau Robusta (Coffea canefora L.) Pada Pasien Diabetes Mellitus

Rusman Rusman, Nur Alfiah Irfiyanti

Abstract

a disease with chronic metabolic disorders characterized by high blood glucose levels as a result of insulin resistance is known as diabetes mellitus. Indonesia is among the 7th of the top 10 countries which are estimated to have a diabetes mellitus sufferer of 5.4 million in 2045 and have a low blood sugar control rate. Robusta coffee is the most popular drink, and contains chlorogenic acid, which has anti-diabetic mellitus properties. This study aims to examine the hard candy formulation of robusta green coffee bean infusion (Coffea canephora L) on blood glucose levels and creatinine levels in patients with type-2 diabetes mellitus. the research method was conducted observational, with the free and post design method. This research was conducted at the Pajjaiang clinic in September-October 2020 on prolanis patients diagnosed with type 2 diabetes mellitus. A total of 25 patients were given Hard candy formulation from robusta green coffee bean infusion for 3-4 weeks. The results of the study based on the SPSS data analysis showed that there was an effect on reducing blood glucose levels in diabetes mellitus patients, and the results of the GFR calculation showed no significant effect on creatinine function in diabetes mellitus patients.

Keywords

Diabetes Mellitus, hard candy, robusta coffee

Full Text:

PDF

References

E. Jean-Marie, “Diagnosis and classification of diabetes mellitus,” in Encyclopedia of Endocrine Diseases, 2018. doi: 10.1016/B978-0-12-801238-3.65822-1.

J. Brown, R. Martis, B. Hughes, J. Rowan, and C. A. Crowther, “Oral anti-diabetic pharmacological therapies for the treatment of women with gestational diabetes,” Cochrane Database Syst. Rev., no. 1, 2017.

J. E. P. (Editors)-M. of I. A. (Medical I. U.-S. (2007). pdf file:///C:/Users/LENOVO/Downloads/Alan R. Saltiel, “Anti-oxidant and anti-diabetic activities of ethanolic extract of Primula Denticulata Flowers,” Indones. J. Pharm., vol. 27, no. 2, pp. 74–79, 2016, doi: 10.14499/indonesianjpharm27iss2pp74.

Z. Kyselova, M. Stefek, and V. Bauer, “Pharmacological prevention of diabetic cataract,” J. Diabetes Complications, vol. 18, no. 2, pp. 129–140, 2004.

R. R. Tjandrawinata, “Patogenesis Diabetes Tipe 2 : Resistensi Defisiensi Insulin,” Dexa Medica Group, no. February, pp. 1–4, 2016.

M. D. José Pedro De La Cruz, M. D. José Antonio González-Correa, M. D. Ana Guerrero, and M. D. Felipe Sánchez de la Cuesta, “Pharmacological approach to diabetic retinopathy,” Diabetes Metab. Res. Rev., vol. 20, no. 2, pp. 91–113, 2004.

L. Costantino, G. Rastelli, M. C. Gamberini, and D. Barlocco, “Pharmacological approaches to the treatment of diabetic complications,” Expert Opin. Ther. Pat., vol. 10, no. 8, pp. 1245–1262, 2000.

R. Levine, Mechanisms of insulin action., vol. 7. 1974. doi: 10.1016/b978-0-12-027307-2.50014-1.

R. K. Prabawati, “Mekanisme Seluler dan Molekular Resistensi Insulin,” Tugas Biokimia Program Pasca Sarj. Ilmu Biomedik Program Double Dolgree Neurol. Fak. Kedokt. Univ. Brawijaya Malang, vol. 1, pp. 1–15, 2012.

F. PDP/19864-40381-1-SM.pdf, “Korelasi Lama Diabetes Melitus Terhadap Kejadian Nefropati Diabetik : Studi Kasus Di Rumah Sakit Dokter Kariadi Semarang,” J. Kedokt. Diponegoro, vol. 2, no. 1, p. 109938, 2013.

F. PDP/49-90-1-SM.pdf, “Screening Fungsi Ginjal Sebagai Perbaikan Outcome Pengobatan Pada Penderita Diabetes Mellitus Tipe Ii (Studi Di Wilayah Kerja Puskesmas Ngesrep),” J. Kesehat. Masy. E-J., vol. 6, no. 1, pp. 191–199, 2018.

B. L. Tahun, S. Alfarisi, W. Basuki, and T. Susantiningsih, “Perbedaan Kadar Kreatinin Serum Pasien Diabetes Melitus Tipe 2 Yang Terkontrol Dengan Yang Tidak Terkontrol Di Rsud Dr . H . Abdul Moeloek Differences in Serum Creatinine Levels of Type 2 Diabetes Mellitus Patient That Controlled With Not Controlled in Dr,” pp. 129–136, 2012.

R. Yamauchi et al., “Coffee and caffeine ameliorate hyperglycemia, fatty liver, and inflammatory adipocytokine expression in spontaneously diabetic KK-Ay mice,” J. Agric. Food Chem., vol. 58, no. 9, pp. 5597–5603, 2010, doi: 10.1021/jf904062c.

K. W. Ong, A. Hsu, and B. K. H. Tan, “Chlorogenic acid stimulates glucose transport in skeletal muscle via AMPK activation: A contributor to the beneficial effects of coffee on diabetes,” PLoS ONE, vol. 7, no. 3, 2012, doi: 10.1371/journal.pone.0032718.

P. Shokouh, P. B. Jeppesen, C. B. Christiansen, F. B. Mellbye, K. Hermansen, and S. Gregersen, “Efficacy of arabica versus robusta coffee in improving weight, insulin resistance, and liver steatosis in a rat model of type-2 diabetes,” Nutrients, vol. 11, no. 9, 2019, doi: 10.3390/nu11092074.

N. Widyastuti, G. Anjani, V. G. Almira, S. E. Putri, and A. R. Pratiwi, “Effects of the administration of brewed robusta coffee leaves on total antioxidant status in rats with high-fat, highfructose diet-induced metabolic syndrome,” Potravinarstvo Slovak J. Food Sci., 2020, doi: 10.5219/1350.

DOI: https://doi.org/10.37311/jsscr.v4i2.14183

Refbacks

There are currently no refbacks.

EDITORIAL OFFICE OF JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Department of Pharmacy, Gorontalo State University

Jl. Jenderal Sudirman No.6, Kota Gorontalo, Provinsi Gorontalo 96128, Indonesia

Email: info.jsscr@ung.ac.id
Google Scholar : JOURNAL SYIFA SCIENCES AND CLINICAL RESEARCH

Journal Syifa Sciences and Clinical Research (JSSCR) is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.

Username
Password
Remember me